JPMorgan Chase & Co’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06K | Buy |
|
|||||
|
2025
Q1 | $43 | Sell |
|
|||||
|
2024
Q4 | $19.6K | Sell |
|
|||||
|
2024
Q3 | $1.02M | Sell |
|
|||||
|
2024
Q2 | $1.06M | Buy |
|
|||||
|
2024
Q1 | $818K | Buy |
|
|||||
|
2023
Q4 | $77.8K | Buy |
|
|||||
|
2023
Q3 | $2.58K | Hold |
|
|||||
|
2023
Q2 | $2.11K | Sell |
|
|||||
|
2023
Q1 | $47K | Buy |
|
|||||
|
2022
Q4 | $54K | Sell |
|
|||||
|
2022
Q3 | $633K | Buy |
|
|||||
|
2022
Q2 | $304K | Buy |
|
|||||
|
2022
Q1 | $427K | Buy |
|
|||||
|
2021
Q4 | $167K | Sell |
|
|||||
|
2021
Q3 | $283K | Buy |
|
|||||
|
2021
Q2 | $334K | Buy |
|
|||||
|
2021
Q1 | $324K | Buy |
|
|||||
|
2020
Q4 | $259K | Buy |
|
|||||
|
2020
Q3 | $262K | Buy |
|
|||||
|
2020
Q2 | $277K | Buy |
|